Gilead Sciences
GILD
#129
Rank
โ‚ฌ129.18 B
Marketcap
104,12ย โ‚ฌ
Share price
-1.14%
Change (1 day)
22.10%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2025 (TTM): โ‚ฌ8.76 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are โ‚ฌ29.08 Billion. In 2024 the company made an earning of โ‚ฌ0.59 Billion a decrease over its 2023 earnings that were of โ‚ฌ5.89 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ8.76 B1379.78%
2024 โ‚ฌ0.59 B-89.94%
2023 โ‚ฌ5.89 B17.97%
2022 โ‚ฌ4.99 B-29.77%
2021 โ‚ฌ7.10 B395.99%
2020 โ‚ฌ1.43 B-67.66%
2019 โ‚ฌ4.43 B-33.84%
2018 โ‚ฌ6.69 B-42.35%
2017 โ‚ฌ11.62 B-20.87%
2016 โ‚ฌ14.68 B-21.06%
2015 โ‚ฌ18.60 B45.8%
2014 โ‚ฌ12.75 B253.01%
2013 โ‚ฌ3.61 B16.51%
2012 โ‚ฌ3.10 B-1.07%
2011 โ‚ฌ3.13 B-6.71%
2010 โ‚ฌ3.36 B11.75%
2009 โ‚ฌ3.00 B29.5%
2008 โ‚ฌ2.32 B19.11%
2007 โ‚ฌ1.94 B-455.74%
2006 -โ‚ฌ0.55 Billion-154.93%
2005 โ‚ฌ0.99 B76.99%
2004 โ‚ฌ0.56 B-266.16%
2003 -โ‚ฌ0.34 Billion-638.24%
2002 โ‚ฌ63.04 M31.5%
2001 โ‚ฌ47.94 M-242.15%
2000 -โ‚ฌ33.73 Million-40.2%
1999 -โ‚ฌ56.4 Million31.85%
1998 -โ‚ฌ42.78 Million8.73%
1997 -โ‚ฌ39.34 Million27.22%
1996 -โ‚ฌ30.93 Million
1994 -โ‚ฌ29.47 Million26.57%
1993 -โ‚ฌ23.28 Million46.49%
1992 -โ‚ฌ15.89 Million362.5%
1991 -โ‚ฌ3.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
โ‚ฌ7.08 B-16.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚ฌ3.83 B-54.87%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ1.42 B-83.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚ฌ0.85 B-89.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ1.63 B-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ10.17 B 19.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ27.82 B 227.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ19.32 B 127.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ19.83 B 133.56%๐Ÿ‡บ๐Ÿ‡ธ USA